Adam Karns
Cardiovascular Medical Group(US)Launchpad Central (United States)(US)
Publications by Year
Research Areas
Blood Pressure and Hypertension Studies, Receptor Mechanisms and Signaling, Hormonal Regulation and Hypertension, Atherosclerosis and Cardiovascular Diseases, Nitric Oxide and Endothelin Effects
Most-Cited Works
- → Study of Aldosterone Synthase Inhibition as an Add‐On Therapy in Resistant Hypertension(2012)91 cited
- → Effects of Xuezhikang in patients with dyslipidemia: A multicenter, randomized, placebo-controlled study(2014)60 cited
- → Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension(2025)19 cited
- → ZILEBESIRAN AS ADD-ON THERAPY IN PATIENTS WITH HYPERTENSION INADEQUATELY CONTROLLED WITH A STANDARD ANTIHYPERTENSIVE MEDICATION: EFFICACY AND SAFETY RESULTS FROM THE KARDIA-2 STUDY(2024)9 cited